I2 Technologies

i2 Pharma is a biotechnology company based in Boulder, Colorado, that specializes in next-generation proteomics and the discovery of high-affinity aptamers. The company utilizes a proprietary platform to develop chemically modified nucleic acid ligands that can act as therapeutic agents or diagnostic tools. Their technology focuses on expanding the chemical diversity of aptamers to improve their binding properties and stability compared to traditional biologics. i2 Pharma's internal pipeline and collaborative efforts target areas such as oncology and infectious diseases, leveraging their ability to rapidly identify and optimize lead candidates. The company operates primarily as a platform-driven drug discovery entity, providing specialized services and partnerships to the broader pharmaceutical industry.